Stock Analysis on Net
Stock Analysis on Net

GlaxoSmithKline PLC (NYSE:GSK)

This company has been moved to the archive! The financial data has not been updated since February 27, 2015.

Analysis of Inventory

Microsoft Excel

Inventory Disclosure

GlaxoSmithKline PLC, balance sheet: inventory

US$ in millions, translated from GBP £

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Raw materials and consumables 1,952 1,553 1,569 1,731 2,256
Work in progress 2,709 2,403 2,174 1,815 1,156
Finished goods 2,484 2,507 2,711 2,472 2,493
Inventories 7,146 6,463 6,455 6,018 5,906

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Item Description The company
Inventories Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. GlaxoSmithKline PLC inventories increased from 2012 to 2013 and from 2013 to 2014.